Literature DB >> 20542576

The emerging role for chemokines in epilepsy.

Paolo F Fabene1, Placido Bramanti, Gabriela Constantin.   

Abstract

Epilepsy has been considered mainly a neuronal disease, without much attention to non-neuronal cells. In recent years growing evidence suggest that astrocytes, microglia, blood leukocytes and blood-brain barrier breakdown are involved in the pathogenesis of epilepsy. In particular, leukocyte-endothelium interactions and eventually subsequent leukocyte recruitment in the brain parenchyma seem to represent key players in the epileptogenic cascade. Chemokines are chemotactic factors controlling leukocyte migration under physiological and pathological conditions. In the light of recent advances in our understanding of the role of inflammation mechanisms in the pathogenesis of epilepsy, pro-inflammatory chemokines may play a critical role in epileptogenesis. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542576     DOI: 10.1016/j.jneuroim.2010.05.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 2.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

3.  Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Nicholas R Rensing; Meihua Yang; Michael Wong
Journal:  Neurobiol Dis       Date:  2015-05-21       Impact factor: 5.996

Review 4.  Use of peripheral blood transcriptome biomarkers for epilepsy prediction.

Authors:  Stanislav L Karsten; Lili C Kudo; Anatol J Bragin
Journal:  Neurosci Lett       Date:  2011-03-17       Impact factor: 3.046

5.  Disease-Modifying Effects of Neural Regeneration Peptide 2945 in the GAERS Model of Absence Epilepsy.

Authors:  Gabi Dezsi; Frank Sieg; Mark Thomas; Terence J O'Brien; Marieke van der Hart; Nigel C Jones
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

6.  Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures.

Authors:  Jayne Abraham; Patrick D Fox; Carlo Condello; Alyssa Bartolini; Sookyong Koh
Journal:  Neurobiol Dis       Date:  2012-02-16       Impact factor: 5.996

7.  Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats.

Authors:  Ruohan Li; Limin Ma; Hao Huang; Shu Ou; Jinxian Yuan; Tao Xu; Xinyuan Yu; Xi Liu; Juan Yang; Yangmei Chen; Xi Peng
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

Review 8.  Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review.

Authors:  Ibraheem Husain; Saima Zameer; Tushar Madaan; Akram Minhaj; Wasim Ahmad; Asif Iqubaal; Abuzer Ali; Abul Kalam Najmi
Journal:  Metab Brain Dis       Date:  2019-03-08       Impact factor: 3.584

Review 9.  Cerebrovascular remodeling and epilepsy.

Authors:  Nicola Marchi; Mireille Lerner-Natoli
Journal:  Neuroscientist       Date:  2012-10-16       Impact factor: 7.519

10.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.